2003, Document, Informed consent and Presentation

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2003

Document

Informed consent

Presentation

Analysis of U.S. Food and Drug Administration Draft Guidance on Clinical Trials with Psychedelic Drugs

Healthcare Law Insights blog

JUNE 30, 2023

Food and Drug Administration (FDA) published a draft guidance document with foundational considerations for researchers that are developing psychedelic drugs for the treatment of medical conditions. The document frequently refers readers to existing guidance while noting key considerations that are unique to psychedelic drugs in each section.

Document

Document Informed consent 2003 2010

Undisclosed Conflicts of Interest by Physicians Creating the CDC Opioid Prescribing Guidelines: Bad Faith or Incompetence?

Pallimed

SEPTEMBER 12, 2022

In November 2003, the Orlando Sentinel published a series of articles on OxyContin, exemplifying the media’s moral panic about opioids (12). Although this reduced Washington state’s Medicaid costs, it contributed “to the deaths of at least 2,173 people between 2003 and late 2011 (23, 25).”

2016

2016 2019 2022 2015

Home Care & Hospice Network

Analysis of U.S. Food and Drug Administration Draft Guidance on Clinical Trials with Psychedelic Drugs

Undisclosed Conflicts of Interest by Physicians Creating the CDC Opioid Prescribing Guidelines: Bad Faith or Incompetence?

Stay Connected